Status:
COMPLETED
Cognitive Behavioral Therapy (CBT) for Adherence and Depression in Type 1 Diabetes
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Depression
Type 1 Diabetes
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
This study is a pilot behavioral intervention trial, designed to initially examine cognitive behavioral therapy for medical adherence and depression (CBT-AD) in patients with depression and poorly con...
Eligibility Criteria
Inclusion
- Diagnosis of type 1 diabetes that is poorly controlled (HbA1C greater than or equal to 8.0%) despite treatment with insulin.
- Diagnosis of major depression and/or dysthymia, or current subclinical symptoms of depression in spite of being treated with antidepressants.
- Age 18-80.
- If on an antidepressant, stable for two months. Oral hypoglycemic medications stable for 2 months, and insulin prescription stable for 2 months (if prescribed).
Exclusion
- Active or untreated major mental illness that would interfere with participation (e.g., untreated psychosis), untreated/unstable bipolar disorder, eating disorder, mental retardation, dementia, or active suicidality.
- Unable or unwilling to provide informed consent.
- History of or current CBT for depression.
- Currently on dialysis.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT01527981
Start Date
March 1 2008
End Date
November 1 2010
Last Update
February 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114